[Paraneoplastic syndromes. Associated with lung cancer]
Francisco Javier Ochoa-Carrillo1, Mariana Chávez-Mac Gregor, Dan Green-Renner
1Instituto Nacional de Cancerología, México DF. gpooncol@prodigy.net.mx
Cirugia Y Cirujanos
|September 22, 2009
Summary
Paraneoplastic syndromes, disorders remote from a primary tumor, are common in lung cancer patients. Understanding their mechanisms aids in diagnosis and treatment of these diverse systemic manifestations.
Area of Science:
- Oncology
- Neurology
- Endocrinology
Context:
- Paraneoplastic syndromes are increasingly recognized complications of primary lung cancer.
- These syndromes manifest remotely from the tumor site, affecting various organ systems.
- They highlight the systemic impact of malignant disease.
Purpose:
- To review paraneoplastic syndromes associated with lung cancer.
- To discuss their potential mechanisms, clinical features, and diagnostic approaches.
- To explore current and emerging treatment strategies.
Summary:
- Paraneoplastic syndromes involve diverse clinical manifestations and are often diagnosed by exclusion.
- Improved understanding of pathogenesis offers new diagnostic and therapeutic avenues.
- This review covers mechanisms, clinical presentation, diagnosis, and treatment of these syndromes in lung cancer.
Impact:
- Enhanced recognition and diagnosis of paraneoplastic syndromes in lung cancer patients.
- Potential for improved patient outcomes through targeted therapies.
- Contributes to a deeper understanding of cancer-host interactions.
Related Concept Videos
01:17Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:29Pneumonia II: Pathophysiology
The pathophysiology of pneumonia involves the following steps:
02:39lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
01:28Pleural Effusion II: Symptoms and Management
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: